Palisade Bio (PALI) News Today → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free PALI Stock Alerts $7.90 -0.56 (-6.62%) (As of 05/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePalisade Bio Appoints Margery Fischbein to its Board of Directorsglobenewswire.com - May 7 at 8:30 AMPalisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rulesglobenewswire.com - May 7 at 7:30 AMMaxim Group Reiterates "Buy" Rating for Palisade Bio (NASDAQ:PALI)americanbankingnews.com - May 3 at 5:32 AMPalisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rulesglobenewswire.com - May 2 at 8:30 AMMarijuana reclassified federally in major win for the legal cannabis industrymsn.com - May 1 at 5:46 PMPalisade Bio stock rallies 50% premarket on colitis drug updatemsn.com - May 1 at 12:46 PMPalisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)finance.yahoo.com - May 1 at 12:46 PMmarketbeat.com - May 1 at 9:55 AMPalisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)globenewswire.com - May 1 at 8:30 AMPalisade Bio, Strand Life Sciences team up on colitis drug researchmsn.com - April 23 at 2:35 PMWhy Palisade Bio Stock Is Up Todaymsn.com - April 23 at 2:35 PMmarketbeat.com - April 23 at 9:42 AMmarketbeat.com - April 23 at 9:42 AMPalisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approachfinance.yahoo.com - April 23 at 9:34 AMPalisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approachglobenewswire.com - April 23 at 8:30 AMLooking Into Palisade Bio's Recent Short Interestbenzinga.com - April 19 at 2:14 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)markets.businessinsider.com - April 17 at 5:31 PMHow Apple Car Key Works (and Why It Still Hasn’t Caught On)msn.com - April 17 at 2:29 AMPalisade Bio stock rallies nearly 100% on colitis drug analysismsn.com - April 16 at 9:28 PMPalisade Bio Shares Surge 80% After Lab Study Results for Ulcerative Colitis Treatmentmarketwatch.com - April 16 at 4:28 PMWhy Palisade Bio Stock Is Soaring Todaymsn.com - April 16 at 4:28 PMWhy Is Palisade Bio (PALI) Stock Up 57% Today?investorplace.com - April 16 at 11:22 AMmarketbeat.com - April 16 at 9:39 AMPalisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stoolfinance.yahoo.com - April 16 at 8:43 AMPalisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients' Stoolglobenewswire.com - April 16 at 8:30 AMPalisade Bio advances ulcerative colitis treatment to Phase 1 studyuk.investing.com - April 12 at 12:54 PMPalisade Bio to Participate in the Virtual Investor Lunch Break Eventglobenewswire.com - April 11 at 9:15 AMPalisade Bio stock slides 8% amid colitis drug presentationmsn.com - April 10 at 1:23 PMPalisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™finance.yahoo.com - April 10 at 8:23 AMPalisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn's & Colitis™globenewswire.com - April 10 at 8:15 AMmarketbeat.com - April 8 at 6:04 AMPalisade Bio Inc 7NSmorningstar.com - April 6 at 12:52 AMPalisade Bio Announces 1-for-15 Reverse Stock Splitglobenewswire.com - April 3 at 5:30 PMPalisade Bio Reports Year End 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - March 27 at 9:56 AMPALI Stock Earnings: Palisade Bio Beats EPS for Q4 2023investorplace.com - March 27 at 1:03 AMPalisade Bio to Present at Digestive Disease Week (DDW) 2024finance.yahoo.com - February 15 at 3:59 PMPalisade Bio to Present at Digestive Disease Week (DDW) 2024globenewswire.com - February 15 at 8:35 AMPalisade Bio, Inc.: Palisade Bio Provides Corporate Update and Reiterates Guidancefinanznachrichten.de - February 13 at 3:55 PMPalisade Names Donald Williams Chairman, Cuts Board Size in Halfmarketwatch.com - February 13 at 10:55 AMPalisade Bio Provides Corporate Update and Reiterates Guidancefinance.yahoo.com - February 13 at 10:55 AMPalisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leadersfinance.yahoo.com - February 8 at 12:21 PMFTC more `focused' on stopping bad deals after Amazon-iRobot - reportmsn.com - January 31 at 12:15 PMPalisade Bio Shares Updates and Drug Candidate Progressmsn.com - January 30 at 4:08 PMPalisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Millionfinance.yahoo.com - January 30 at 10:24 AMPalisade Bio Shares Drop 23% After Warrants Exercisedmarketwatch.com - January 30 at 10:24 AMPalisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Millionfinance.yahoo.com - January 30 at 10:24 AMWhy Is Palisade Bio (PALI) Stock Up 100% Today?investorplace.com - January 29 at 3:03 PMPalisade Bio, Inc.: Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn's & Colitis Congressfinanznachrichten.de - January 29 at 12:28 PMPalisade stock soars 150% on cancelled offering, potential reverse splitmsn.com - January 29 at 12:28 PMPalisade stock soars 150% on canceled offering, potential reverse splitseekingalpha.com - January 29 at 12:28 PM Get Palisade Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter. Email Address Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide PALI Media Mentions By Week PALI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PALI News Sentiment▼0.290.39▲Average Medical News Sentiment PALI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PALI Articles This Week▼102▲PALI Articles Average Week Get Palisade Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FRTX News CELZ News TTNP News TCON News FNCH News KRBP News ALBT News ELOX News PSTV News GMDA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PALI) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe Gold Grab of the CenturyColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palisade Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
